Aphthous ulcers in HIV-infected patients: treatment with thalidomide. 1992

S Strazzi, and C Lebbe, and C Geoffray, and G Ablon, and P Morel, and O Verola, and J M Molina

UI MeSH Term Description Entries
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013281 Stomatitis, Aphthous A recurrent disease of the oral mucosa of unknown etiology. It is characterized by small white ulcerative lesions, single or multiple, round or oval. Two to eight crops of lesions occur per year, lasting for 7 to 14 days and then heal without scarring. (From Jablonski's Dictionary of Dentistry, 1992, p742) Aphthae,Canker Sore,Periadenitis Mucosa Necrotica Recurrens,Ulcer, Aphthous,Aphthous Stomatitides,Aphthous Stomatitis,Aphthous Ulcer,Aphthous Ulcers,Canker Sores,Sore, Canker,Sores, Canker,Stomatitides, Aphthous,Ulcers, Aphthous
D013792 Thalidomide A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action. Sedoval,Thalomid
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

S Strazzi, and C Lebbe, and C Geoffray, and G Ablon, and P Morel, and O Verola, and J M Molina
October 1997, The New England journal of medicine,
S Strazzi, and C Lebbe, and C Geoffray, and G Ablon, and P Morel, and O Verola, and J M Molina
February 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
S Strazzi, and C Lebbe, and C Geoffray, and G Ablon, and P Morel, and O Verola, and J M Molina
November 1995, GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies,
S Strazzi, and C Lebbe, and C Geoffray, and G Ablon, and P Morel, and O Verola, and J M Molina
September 1993, Pediatric dermatology,
S Strazzi, and C Lebbe, and C Geoffray, and G Ablon, and P Morel, and O Verola, and J M Molina
December 1996, Gastrointestinal endoscopy,
S Strazzi, and C Lebbe, and C Geoffray, and G Ablon, and P Morel, and O Verola, and J M Molina
February 1994, Oral surgery, oral medicine, and oral pathology,
S Strazzi, and C Lebbe, and C Geoffray, and G Ablon, and P Morel, and O Verola, and J M Molina
January 1994, Palliative medicine,
S Strazzi, and C Lebbe, and C Geoffray, and G Ablon, and P Morel, and O Verola, and J M Molina
February 1989, BMJ (Clinical research ed.),
S Strazzi, and C Lebbe, and C Geoffray, and G Ablon, and P Morel, and O Verola, and J M Molina
February 1999, Journal of pediatric gastroenterology and nutrition,
S Strazzi, and C Lebbe, and C Geoffray, and G Ablon, and P Morel, and O Verola, and J M Molina
February 1993, Journal of the American Academy of Dermatology,
Copied contents to your clipboard!